Jounce Therapeutics, Inc.
JNCE · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $51 | -$31 | -$34 | -$37 |
| Dep. & Amort. | $0 | $0 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2 | $3 | $2 | $3 |
| Change in WC | $5 | -$4 | $7 | $0 |
| Other Non-Cash | $0 | $0 | $0 | $0 |
| Operating Cash Flow | $59 | -$32 | -$23 | -$33 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$25 |
| Inv. Sales/Matur. | $14 | $31 | $41 | $23 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $14 | $31 | $41 | -$2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $0 | $0 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $73 | -$1 | $17 | -$35 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $78 | $79 | $62 | $97 |
| End Cash | $152 | $78 | $79 | $62 |
| Free Cash Flow | $59 | -$32 | -$24 | -$33 |